Has Justin Douglas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,134 in general payments to Justin Douglas, MD across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Justin Douglas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Justin Douglas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Justin Douglas, MD

Otolaryngology · Beckley, WVNPI 1326210857

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $990, 2.2 times the $460 reported in 2019.

$4,134in general payments, 2019–2025

Across 142 payments — averaging $29.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$818
GSK$743
Stryker$690
Regeneron Healthcare Solutions, Inc.$430
Acclarent, Inc$383
Optinose US, Inc.$323
plus $746 from 12 others

What the payments were for

Food & beverage$4,134100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	17	$818
GSK	38	$743
Stryker	16	$690
Regeneron Healthcare Solutions, Inc.	19	$430
Acclarent, Inc	12	$383
Optinose US, Inc.	17	$323
AstraZeneca	4	$187
Integra Lifesciences Corporation	2	$135
Intersect ENT, Inc.	1	$73
Smith+Nephew	4	$72
Ambu Inc.	2	$51
Takeda Pharmaceuticals U.S.A., Inc.	1	$42
Johnson & Johnson	1	$40
Merck	2	$38
Aerin Medical Inc.	2	$37
Galderma Laboratories, L.p.	2	$33
Medtronic	1	$21
Hill Dermaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$226
ENTELLUS - XPRESS ENT DILATION SYSTEM$160
ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$160
XPRESS ENT DILATION SYSTEM$122
Acclarent Aera$119
Inspira Air$119
RELIEVA SPINPLUS NAV$119
TruDi Probe$119
BRILINTA$104
Inspire$103

How this compares

$4,134 in reported general payments places this provider in the 85th percentile of 48 otolaryngology providers in West Virginia.

See all otolaryngology providers in West Virginia →

Medicare billing

Part B allowed, 2024

$87,973

Medicare patients

385

Services billed

1,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	12	$44,726
Azelastine Hcl	125	$3,371
Famotidine	130	$2,142
Fluticasone Propionate	107	$1,506
Ipratropium Bromide	53	$1,453
Fluocinolone Acetonide Oil	23	$664
Montelukast Sodium	31	$255
Omeprazole	27	$237
Acetic Acid	13	$205
Ciprofloxacin Hcl	12	$180
Mupirocin	29	$174
Levothyroxine Sodium	16	$102
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	24	$69
Cephalexin	22	$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Beckley

David BlaineBeckley$3K
Rusha PatelMorgantown$11K
Daniel MerendaBridgeport$10K
Jenny CrossElkins$10K
Meghan TurnerMorgantown$9K
Jeffson ChungMorgantown$9K
Kevin OxleyBridgeport$7K
Christopher TiuWheeling$3K
Patrick MaibergerMartinsburg$3K
John WadePoint Pleasant$2K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →